Skip to main content

Table 1 Total number of bone metastases in control and Sunitinib groups

From: Preclinical evaluation of Sunitinib as a single agent in the prophylactic setting in a mouse model of bone metastases

Group Mice Nr. Total Nr.of metastasis at 4 weeks Total Nr.of metastasis at 5 weeks
Control 7 14 21
Sunitinib (40 mg/kg/day) 7 12 21
  1. Fluorescent bone metastatic lesions were counted at week 4 and week 5 following tumor cell inoculation. No significant differences in the mean number of metastases was observed between groups.